PRESS DIGEST-Financial Times - Jan 21

Reuters
01/21
PRESS DIGEST-Financial Times - Jan 21

Jan 21 (Reuters) - The following are the top stories in the Financial Times. Reuters has not verified these stories and does not vouch for their accuracy.

Headlines

Three Ireland owner in talks over sale to Liberty Global

GSK to buy U.S. biotech behind food allergy drug for $2.2 billion

Renault to team up with French defence group to make drones for Ukraine

Independent to take over operations of London's Standard

Overview

CK Hutchison 0001.HK is in talks to sell its Irish mobile operator to Liberty Global LBTYA.O as the Hong Kong-based conglomerate continues to offload its European telecoms businesses.

GSK GSK.L has agreed to acquire Rapt Therapeutics RAPT.O, a US-based biotech whose leading drug combats food allergies, in a deal that values the company at $2.2 billion.

Renault RENA.PA has reached a deal with a French defence company Turgis Gaillard to make drones for Ukraine, in a move backed by France's defence ministry to support Kyiv against Russian aggression.

The UK's Independent Media is in advanced talks to take over the digital and commercial operations of loss making London newspaper The Standard.

(Compiled by Bengaluru newsroom)

((globalnewsmonitoring@thomsonreuters.com))

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10